Comparative efficacy and safety of anticoagulants for prevention of venous thromboembolism after hip and knee arthroplasty (original) (raw)
Apixaban versus enoxaparin in the prevention of venous thromboembolism following total knee arthroplasty: a single-centre, single-surgeon, retrospective analysis
Peter Vale
Internal Medicine Journal, 2016
View PDFchevron_right
Enoxaparin versus dabigatran or rivaroxaban for thromboprophylaxis after hip or knee arthroplasty
Sam Schulman
… Quality and Outcomes, 2010
View PDFchevron_right
Dabigatran versus enoxaparin for prevention of venous thromboembolism after hip or knee arthroplasty: A pooled analysis of three trials
Nadia Rosencher
Thrombosis Research, 2010
View PDFchevron_right
Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial
James Muntz, Ola Dahl
The Lancet, 2008
View PDFchevron_right
Comparing Prophylactic Effect of Rivaroxaban and Enoxaparin on Thromboembolism After Total Hip or Knee Arthroplasty
Mani Mahmoudi
Journal of Research in Orthopedic Science, 2020
View PDFchevron_right
Effect of Aspirin vs Enoxaparin on Symptomatic Venous Thromboembolism in Patients Undergoing Hip or Knee Arthroplasty
David Lieu
JAMA
View PDFchevron_right
Articles Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial
Ákos F Pap
2020
View PDFchevron_right
Therapeutic potential of apixaban in the prevention of venous thromboembolism in patients undergoing total knee replacement surgery
roberto manfredini
Journal of Thrombosis and Thrombolysis, 2012
View PDFchevron_right
Rivaroxaban in the Prophylaxis Against Venous Thromboembolism After Total Knee Arthroplasty- a Prospective Study in a Tertiary Care Centre
abhilash rao
International Journal of Medical and Biomedical Studies, 2020
View PDFchevron_right
Rivaroxaban versus enoxaparin for thromboprophylaxis after total hip or knee arthroplasty: a meta-analysis of randomized controlled trials
William Fisher
European Journal of Clinical Pharmacology, 2010
View PDFchevron_right
Prevention of venous thromboembolism with rivaroxaban and apixaban in orthopedic surgery
Miodrag Vukcevic
Srpski arhiv za celokupno lekarstvo
View PDFchevron_right
Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial
Nadia Rosencher
Journal of Thrombosis and Haemostasis, 2007
View PDFchevron_right
The Incidence of Symptomatic Venous Thromboembolism During and After Prophylaxis With EnoxaparinA Multi-institutional Cohort Study of Patients Who Underwent Hip or Knee Arthroplasty
Shivesh Shah
Archives of Internal Medicine, 1998
View PDFchevron_right
Is aspirin still relevant as a single pharmacological agent for venous thromboembolism prophylaxis post hip and knee arthroplasty surgery: A retrospective review
IMRAN AZEEM
SICOT-J
View PDFchevron_right
Efficacy and safety of venous thromboembolism prophylaxis with apixaban in major orthopedic surgery
Kai Halbritter
Therapeutics and Clinical Risk Management, 2012
View PDFchevron_right
Fondaparinux vs Enoxaparin for the Prevention of Venous Thromboembolism in Major Orthopedic SurgeryA Meta-analysis of 4 Randomized Double-blind Studies
Michael Rud Lassen
Archives of Internal Medicine, 2002
View PDFchevron_right
Rationale and design of XAMOS: noninterventional study of rivaroxaban for prophylaxis of venous thromboembolism after major hip and knee surgery
Sylvia Haas
Vascular Health and Risk Management, 2012
View PDFchevron_right
Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial
Martin Prins
The Lancet, 2007
View PDFchevron_right
Comparison of ximelagatran, an oral direct thrombin inhibitor, with enoxaparin for the prevention of venous thromboembolism following total hip replacement. A randomized, double-blind study
Jeffrey Ginsberg
Journal of Thrombosis and Haemostasis, 2003
View PDFchevron_right
Concomitant use of medication with antiplatelet effects in patients receiving either rivaroxaban or enoxaparin after total hip or knee arthroplasty
Nadia Rosencher, Ola Dahl
2012
View PDFchevron_right
Oral rivaroxaban for the prevention of symptomatic venous thromboembolism after elective hip and knee replacement
Agg Turpie
The Journal of Bone and Joint Surgery. British volume, 2009
View PDFchevron_right
Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial
Gary Raskob
The Lancet, 2010
View PDFchevron_right
Dabigatran, Rivaroxaban and Apixaban versus Enoxaparin for thomboprophylaxis after total knee or hip arthroplasty: Pool-analysis of phase III randomized clinical trials
Timoteo Gonzalez
Thrombosis Research, 2012
View PDFchevron_right
A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial
Ola Dahl
Journal of Thrombosis and Haemostasis, 2005
View PDFchevron_right
Dabigatran Etexilate for the Prevention of Venous Thromboembolism in Patients Undergoing Elective Hip or Knee Surgery
D Papaioannou
PharmacoEconomics, 2012
View PDFchevron_right
Thromboprophylactic treatment with rivaroxaban or dabigatran compared with enoxaparin or dalteparin in patients undergoing elective hip- or knee replacement surgery
Vida Hamidi
2011
View PDFchevron_right
Efficacy and safety of anticoagulants for postoperative thrombophylaxis in total hip and knee arthroplasty: A PRISMA-compliant Bayesian network meta-analysis
Tailai He
PLOS ONE, 2021
View PDFchevron_right
Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty
Menno Huisman
New England Journal of Medicine, 2008
View PDFchevron_right
Apixaban Versus Enoxaparin in Elective Major Orthopedic Surgery: A Clinical Review
Marco Caforio
Clinical and Applied Thrombosis/Hemostasis, 2014
View PDFchevron_right
Thromboprophylaxis in Patients undergoing Orthopedic Surgeries; Focus on cost-effective analysis and safety comparison between Rivaro Rivaroxaban and Enoxaparin
Emad Gaber
2017
View PDFchevron_right